U.S. Stem Cell, Inc. (USRM)
0.0002
0.00 (0.00%)
USD |
OTCM |
Oct 23, 16:00
U.S. Stem Cell Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 75.50% |
| September 30, 2022 | 63.38% |
| June 30, 2022 | 74.69% |
| March 31, 2022 | 68.67% |
| December 31, 2021 | 63.56% |
| September 30, 2021 | 75.22% |
| June 30, 2021 | 61.58% |
| March 31, 2021 | 81.64% |
| December 31, 2020 | 90.81% |
| September 30, 2020 | 71.36% |
| June 30, 2020 | 57.43% |
| March 31, 2020 | 68.52% |
| December 31, 2019 | 45.03% |
| September 30, 2019 | 12.26% |
| June 30, 2019 | 61.02% |
| March 31, 2019 | 60.11% |
| December 31, 2018 | 70.24% |
| September 30, 2018 | 63.80% |
| June 30, 2018 | 68.84% |
| March 31, 2018 | 70.56% |
| December 31, 2017 | 63.42% |
| September 30, 2017 | 64.43% |
| June 30, 2017 | 67.25% |
| March 31, 2017 | 68.54% |
| December 31, 2016 | 73.91% |
| Date | Value |
|---|---|
| September 30, 2016 | 54.23% |
| June 30, 2016 | 65.11% |
| March 31, 2016 | 78.13% |
| December 31, 2015 | 81.75% |
| September 30, 2015 | 56.01% |
| June 30, 2015 | 60.22% |
| March 31, 2015 | 49.14% |
| December 31, 2014 | 0.00% |
| September 30, 2014 | 9.42% |
| June 30, 2014 | 78.23% |
| March 31, 2014 | 70.46% |
| December 31, 2013 | 67.01% |
| September 30, 2013 | |
| June 30, 2013 | 97.51% |
| March 31, 2013 | 80.95% |
| December 31, 2012 | 73.38% |
| September 30, 2012 | 17.07% |
| June 30, 2012 | -44.44% |
| March 31, 2012 | 88.15% |
| December 31, 2011 | 45.71% |
| September 30, 2011 | -122.9% |
| June 30, 2011 | -197.1% |
| March 31, 2011 | |
| December 31, 2010 | -160.0% |
| September 30, 2010 | -120.3% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Myriad Genetics, Inc. | 62.51% |
| BioRestorative Therapies, Inc. | -157.8% |
| Elite Health Systems, Inc. | 7.33% |
| Marijuana, Inc. | -- |
| CareDx, Inc. | 73.37% |